Antimicrobial sulfonamides clear latent Kaposi sarcoma herpesvirus infection and impair MDM2-p53 complex formation.

about

Syntheses of Novel 4-Substituted N-(5-amino-1H-1,2,4-triazol-3-yl)pyridine-3-sulfonamide Derivatives with Potential Antifungal Activity.

P2860

Q46266827-C2BACCC0-F0A7-43DC-A5EE-FA8798D9C48B

P2860

Antimicrobial sulfonamides clear latent Kaposi sarcoma herpesvirus infection and impair MDM2-p53 complex formation.

Item

http://www.wikidata.org/entity/Q40161262

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Antimicrobial sulfonamides cle ...... ir MDM2-p53 complex formation.

@en

type

Item

label

Antimicrobial sulfonamides cle ...... ir MDM2-p53 complex formation.

@en

prefLabel

Antimicrobial sulfonamides cle ...... ir MDM2-p53 complex formation.

@en

P1476

Antimicrobial sulfonamides cle ...... air MDM2-p53 complex formation

@en

P2093

Angela Ingianni

http://www.w3.org/2001/XMLSchema#string

Clelia Madeddu

http://www.w3.org/2001/XMLSchema#string

Rachele Bigi

http://www.w3.org/2001/XMLSchema#string

Raffaello Pompei

http://www.w3.org/2001/XMLSchema#string

Roberto Serpe

http://www.w3.org/2001/XMLSchema#string

Sabrina Uda

http://www.w3.org/2001/XMLSchema#string

Wuguo Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Targeting KSHV/HHV-8 latency with COX-2 selective inhibitor nimesulide: a potential chemotherapeutic modality for primary effusion lymphoma

High-density lipoprotein contribute to G0-G1/S transition in Swiss NIH/3T3 fibroblasts

Tetrahydrobiopterin biosynthesis as an off-target of sulfa drugs

Discovery of selective inhibitors against EBNA1 via high throughput in silico virtual screening

KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine.

Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases

Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma.

Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis.

Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis

Functional p53 signaling in Kaposi's sarcoma-associated herpesvirus lymphomas: implications for therapy.

P2888

ja.2017.67

P304

962-966

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/JA.2017.67

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

D Dittmer

Fabrizio Angius

Enrica Piras

P577

2017-06-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28611469

http://www.w3.org/2001/XMLSchema#string

P932

6002838

http://www.w3.org/2001/XMLSchema#string

Antimicrobial sulfonamides clear latent Kaposi sarcoma herpesvirus infection and impair MDM2-p53 complex formation.

about

P2860

P2860

Antimicrobial sulfonamides clear latent Kaposi sarcoma herpesvirus infection and impair MDM2-p53 complex formation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P932